Search results
Alembic Pharma stock rallies 5% after firm receives USFDA tentative approval for Bosutinib tablets
CNBC Awaaz· 23 hours agoAlembic Pharmaceuticals has received tentative approval from the US Food & Drug Administration...
Alembic Pharma gains nearly 5% on tentative USFDA nod for leukemia drug - CNBC TV18
CNBC TV18· 1 day agoIn a filing to the stock exchanges, the company said that it has received tentative approval from...
ASCO24: Novartis’ Scemblix outperforms standard of care in CML
Pharmaceutical Technology· 7 days agoThe results from the open-label Phase III ASC4FIRST study (NCT04971226) were released in a...